MedTrace Logo

Integrative Oncology Outcomes Study in Breast Cancer

NCT01366248 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750

Last updated 2018-03-22

No results posted yet for this study

Summary

This NIH-NCCAM funded epidemiologic research is being conducted as an observational prospective case-control study of the use of Complementary and Alternative Medicine (CAM) and Integrated Oncology (IO) and their effects on breast cancer patients in community settings.

Hypothesis: IO services improve patients' quality of life and decrease cancer recurrence rates in breast cancer patients as compared to women with similar disease states and prognoses who do not receive IO care, and may or may not use CAM treatment on their own.

Conditions

Sponsors & Collaborators

  • Fred Hutchinson Cancer Center

    collaborator OTHER

  • National Institutes of Health (NIH)

    collaborator NIH

  • National Center for Complementary and Integrative Health (NCCIH)

    collaborator NIH

  • Lotte & John Hecht Memorial Foundation

    collaborator OTHER

  • Bastyr University

    lead OTHER

Principal Investigators

  • Leanna J. Standish, ND, PhD, FABNO · Bastyr University

  • M. Robyn Andersen, PhD, MPH · Fred Hutchinson Cancer Center

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01366248 on ClinicalTrials.gov